Men's Skincare Daily Facebook ad: “30 years of eye bags GONE in 13 days”

Running for 8 days since October 26, 2026. Crush last saw it on November 3, 2026.
Run by Men's Skincare Daily on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 29325684080453041
- Platforms
- Facebook, Instagram, WhatsApp and Threads
- Relaunches
- 0
- Niche
- Skincare & Beauty
Ad text
Most men with persistent under-eye bags have been failing at the same problem for a decade, and almost none of them know why. They sleep eight hours. They drink water. They exercise. Their bloodwork is clean. They have tried retinol, vitamin C, caffeine rollers, hyaluronic acid creams, a $90 jar of La Mer, and at least one jar of beef tallow because the internet told them to. The bags are still there. They are usually worse. The standard explanation men are given by their dermatologist is that the bags are a mix of aging, genetics, and "fluid retention." They are then sold an eye cream. When the eye cream fails, which it almost always does, they are sold a stronger eye cream. When that also fails, they are offered tear trough fillers at approximately $1,200 per session, which must be repeated every six to nine months for the rest of the patient's life. When the patient gets tired of paying the subscription, they are offered blepharoplasty surgery at approximately $7,000, which removes tissue without addressing the underlying drainage failure, and which has a recurrence rate the industry does not advertise. This is the conveyor belt. It is not a treatment plan. It is a revenue model. The reason it persists is that the real mechanism behind male under-eye bags has been well documented in pharmacology for over fifty years and has been systematically ignored by consumer dermatology because acknowledging it would collapse three of the industry's four highest-margin revenue lines. The mechanism is simple and it comes down to physics. Male skin is between 20 and 25 percent thicker than female skin. Testosterone fortifies the outer layer, called the stratum corneum, into a dense multi-layered barrier. There is a principle in pharmacology called the 500-Dalton Rule, which states that any compound heavier than 500 Daltons cannot passively cross an intact adult skin barrier in therapeutic concentrations. Most active ingredients in eye creams are technically under 500 Daltons. Vitamin C weighs 176 Daltons. Caffeine weighs 194. Retinol weighs 286. Niacinamide weighs 122. In theory, they should penetrate. On female skin, some of them partially do. On male skin, they do not. The compounds degrade, dissipate, and get trapped in the outermost layer of dead skin cells. They moisturize the surface. They never reach 0.3mm deep, which is the depth at which the pooled lymphatic fluid, the failing blood vessels, and the collapsed collagen that actually cause eye bags are located. The bags under a man's eyes are not dry skin. They are a plumbing problem. The lymphatic drainage system underneath the eye has slowed, fluid is pooling in the gaps where collagen used to hold tissue tight, and no topical product that cannot cross the barrier can address any of it. The surgery that removes the bagged tissue does not repair the drainage, which is why the bags often return within a year. The only intervention that mechanically addresses the problem without surgery is transdermal microneedle delivery, a technology pharmaceutical companies have used since the 1990s for insulin administration, vaccines, and hormone therapy. A transdermal microneedle patch for eye bags contains approximately 1,500 dissolving microneedles, thinner than a human hair, that physically breach the skin barrier rather than chemically negotiate with it. The needles penetrate to exactly 0.3mm, which is the depth at which the drainage system, the vascular network, and the collagen matrix are located. They deposit 300-Dalton peptides and 39 percent high-purity hyaluronic acid directly into the dermal tissue, where the damage actually lives. Not on the barrier. Through it. The technology has been standard in Korean dermatology clinics since approximately 2018. It has been quietly available in the United States for a shorter window, largely because the American aesthetic medicine industry is worth $18 billion a year and a $38 patch that performs what a $1,200 filler appointment performs collapses the math.
Where the ad sends people
tryoros.com
30 years of eye bags GONE in 13 days
230,000+ Sold
Learn more: tryoros.com(opens in a new tab)










